As of 2025-07-04, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is 553.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.29 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is 7498.3%.
The range of the Relative Valuation is 434.33 - 671.34 USD.
| Range | Selected | |
| Trailing P/E multiples | 28.3x - 34.9x | 33.6x |
| Forward P/E multiples | 29.3x - 39.6x | 31.2x |
| Fair Price | 434.33 - 671.34 | 553.92 |
| Upside | 5857.9% - 9109.1% | 7498.3% |
| Date | P/E |
| 2025-06-27 | 0.39 |
| 2025-06-26 | 0.39 |
| 2025-06-25 | 0.38 |
| 2025-06-24 | 0.38 |
| 2025-06-23 | 0.37 |
| 2025-06-20 | 0.37 |
| 2025-06-18 | 0.37 |
| 2025-06-17 | 0.37 |
| 2025-06-16 | 0.37 |
| 2025-06-13 | 0.37 |
| 2025-06-12 | 0.37 |
| 2025-06-11 | 0.37 |
| 2025-06-10 | 0.37 |
| 2025-06-09 | 0.37 |
| 2025-06-06 | 0.37 |
| 2025-06-05 | 0.37 |
| 2025-06-04 | 0.37 |
| 2025-06-03 | 0.37 |
| 2025-06-02 | 0.36 |
| 2025-05-30 | 0.36 |
| 2025-05-29 | 0.36 |
| 2025-05-28 | 0.36 |
| 2025-05-27 | 0.36 |
| 2025-05-23 | 0.35 |
| 2025-05-22 | 0.35 |
| 2025-05-21 | 0.35 |
| 2025-05-20 | 0.35 |
| 2025-05-19 | 0.35 |
| 2025-05-16 | 0.36 |
| 2025-05-15 | 0.35 |
| 2025-05-14 | 0.36 |
| 2025-05-13 | 0.35 |
| 2025-05-12 | 0.35 |
| 2025-05-09 | 0.34 |
| 2025-05-08 | 0.34 |
| 2025-05-07 | 0.33 |
| 2025-05-06 | 0.33 |
| 2025-05-05 | 0.33 |
| 2025-05-02 | 0.33 |
| 2025-05-01 | 0.33 |
| 2025-04-30 | 0.33 |
| 2025-04-29 | 0.33 |
| 2025-04-28 | 0.33 |
| 2025-04-25 | 0.33 |
| 2025-04-24 | 0.32 |
| 2025-04-23 | 0.31 |
| 2025-04-22 | 0.30 |
| 2025-04-21 | 0.29 |
| 2025-04-17 | 0.31 |
| 2025-04-16 | 0.30 |